Who invested in Amylon Therapeutics?
Amylon Therapeutics's investors include UNIIQ.

Funding summaryUpdated 26 Oct 2026
$349Kraised across 1 round since 2017, from 1 source
Amylon Therapeutics's investors include UNIIQ.
Amylon Therapeutics has raised $349K across 1 round since 2017.
Amylon Therapeutics's most recent round was a Seed of $349K in Nov 2017.
Its most recent round, $349K in Nov 2017, is also its largest on record.
Amylon Therapeutics's first round on record, in Nov 2017, was backed by UNIIQ.
Amylon Therapeutics's latest named round is a Seed, in Nov 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.